Parkinson's patients get extended safety watch on experimental brain infusion
NCT ID NCT07214285
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 26 times
Summary
This study follows one Parkinson's patient who has been receiving A-dopamine directly into the brain for years. The goal is to monitor long-term safety and carefully reduce the dose to avoid sudden withdrawal. Researchers will also help transition to an alternative treatment if needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UHLillle
RECRUITINGLille, Haut de France, 59000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.